About this trial
The main goal of this project is to see if RADAR (Rapid AI-assisted Detection and Analysis of Rheumatic heart disease), which is a machine and deep-learning AI model, can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.
Eligibility criteria
Qualifiers
Employed at a participating ADUNU facility
Holds a designated role in the ADUNU program as a nurse screener
Disqualifiers
None. The pragmatic trial design includes all eligible staff at participating facilities.
Trial design
Treatments tested in this trial
- AI assisted echocardiography
Treatment groups
Sponsors and collaborators
Children's Hospital Medical Center, Cincinnati
Lead sponsor
Uganda Heart Institute
Collaborator
Ochsner Health System
Collaborator
Vanderbilt University Medical Center
Collaborator
Children's National Health Center
Collaborator